Keyxone TZ 500mg/62.5mg Injection
Marketer
Geologic Labs Pvt. Ltd.
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Keyxone TZ 500mg/62.5mg Injection
Combiflox TZ 500mg/62.5mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration must be under a physician's direct supervision; adhere strictly to the prescribed dosage schedule. Complete the entire treatment course, regardless of symptom improvement; premature cessation can compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects necessitate immediate medical consultation. Seek urgent medical attention for allergic reactions (e.g., skin rashes, pruritus, edema, dyspnea). Inform your physician of all current medications prior to commencing treatment. Pregnant or lactating individuals should seek medical advice before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Ensure adequate rest, nutrition, and hydration for optimal recovery. Your doctor may order lab tests to monitor treatment response.
Primary Ingredients of Keyxone TZ 500mg/62.5mg Injection
No text provided to rephrase.
Uses of Keyxone TZ 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Keyxone TZ 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Keyxone TZ 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Keyxone TZ 500mg/62.5mg Injection:
Administering this medication will be handled by your physician or their nursing staff; self-medication is strictly prohibited.
How Keyxone TZ 500mg/62.5mg Injection works:
Keyxone TZ 500mg/62.5mg injection unites the antibacterial actions of Ceftriaxone and Tazobactum. Ceftriaxone, an antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Keyxone TZ 500mg/62.5mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
Keyxone TZ 500mg/62.5mg injections are typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harm to the fetus; nonetheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Keyxone TZ 500mg/62.5mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Keyxone TZ 500mg/62.5mg Injection can potentially reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Keyxone TZ 500mg/62.5mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication Keyxone TZ 500mg/62.5mg requires careful administration in individuals with significant hepatic impairment, potentially necessitating dose modification. Consult a physician for guidance. Altering the Keyxone TZ 500mg/62.5mg injection dosage is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Keyxone TZ 500mg/62.5mg Injection :
Should you forget a scheduled Keyxone TZ 500mg/62.5mg Injection, seek medical advice.
Facts to Know About Keyxone TZ 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently